By Mitul Agarwal, B.Pharm, MBA. Published October 2026.
Short answer: a CRO (contract research organisation) runs research and studies for you, such as clinical trials and bioequivalence studies. A CMO (contract manufacturing organisation) makes your product to a process you already have. A CDMO (contract development and manufacturing organisation) does both development and manufacturing: it can take a molecule or idea through formulation, scale-up and stability to commercial batches. Many companies now offer more than one of these, so ask what a partner actually does, not what it calls itself.
The full forms
- CRO: Contract Research Organisation.
- CMO: Contract Manufacturing Organisation. (In a company's management team, CMO can also mean Chief Medical Officer or Chief Marketing Officer. In outsourcing, it means the manufacturer.)
- CDMO: Contract Development and Manufacturing Organisation.
- CRDMO: Contract Research, Development and Manufacturing Organisation, a term used by several Indian and Chinese companies that offer discovery chemistry as well.
- CSO: Contract Sales Organisation, which provides sales teams rather than science or plants.
Side by side
| CRO | CDMO | CMO | |
|---|---|---|---|
| Main job | Research and studies | Develops and then makes the product | Makes the product to your process |
| Typical work | Clinical trials, bioequivalence (BA/BE) studies, preclinical tests, bioanalysis, data management, regulatory writing | Formulation, analytical methods, scale-up, stability studies, tech transfer, clinical and commercial batches, CMC documents for the dossier | Commercial manufacturing, packing, release testing |
| You bring | A protocol or a question to answer | A molecule, a target product or an existing product to improve | A validated process and specifications |
| Main quality standard | GCP (ICH E6) for trials; GLP for non-clinical labs | GMP, plus development data that meets ICH guidelines | GMP |
| What you get | Study reports and data | A product, its process and the technical documents | Released batches |
| Key contract | Service agreement and study protocol | Development agreement, supply agreement and quality agreement | Supply agreement and quality agreement |
When you need which
- You have a new molecule and need human data: a CRO runs the trials. A CDMO makes the clinical supplies.
- You want a generic for your market and have no dossier: a CDMO can develop the formulation and run stability studies. A CRO runs the bioequivalence study that most regulators require. Some CDMOs arrange the BE study through a partner CRO. Alternatively, you can license an existing dossier (see out-licensing a generic dossier).
- You already have a registered product and need more capacity or a second source: a CMO is enough. Plan the tech transfer and the registration variation.
- You only want to sell under your own brand: white label may be faster than either, because the product is already developed and registered. See our white-label manufacturing service.
How the three work together on one product
Take a company that wants to launch a generic tablet in several emerging markets:
- Development (CDMO): the CDMO sources the API, develops a formulation that matches the reference product, validates the test methods and makes pilot batches.
- Stability (CDMO): the pilot batches go on stability studies at the climate conditions of the target markets.
- Bioequivalence (CRO): a CRO compares the new tablet with the reference product in healthy volunteers and writes the study report.
- Dossier: the CDMO writes the quality (CMC) sections, the CRO supplies the bioequivalence report, and the company files the dossier with each regulator.
- Commercial supply (CDMO or CMO): once registered, the same site makes commercial batches, or the process is transferred to a CMO with more capacity or lower cost.
A single company can play all three roles, but the work and the standards behind each step are different. Check each one separately.
How they charge
- CROs usually price per study, broken into a budget per activity (sites, patients or volunteers, monitoring, lab work, report). Long programmes may use a dedicated team billed per person (FTE).
- CDMOs price development as fee-for-service work packages or milestones, then quote commercial supply per batch or per unit. Some offer lower development fees in exchange for a long supply contract.
- CMOs quote per batch or per unit, often with a minimum order and a technology-transfer fee at the start.
Who owns what
This is the question buyers forget to ask until it is too late.
- With a CRO, the sponsor normally owns the study data and reports.
- With a CDMO, ownership of the formulation, the process know-how and the dossier must be written into the development agreement. Some CDMOs develop at their own cost and keep the dossier, then license it. Others develop for a fee and hand everything over.
- With a CMO, you own the product and process. The manufacturer owns its plant know-how and equipment.
Whichever model you choose, agree who holds the dossier, who can file it in which countries, and what happens if you move production elsewhere.
What to check before you sign
- Approvals that match your market. A WHO-GMP site may suit many emerging markets but not the EU or US. Look at the inspection history, not just the certificate. See which certifications actually matter.
- Real experience with your dosage form. Ask for products of the same type the site already makes, and for its batch sizes.
- For a CRO: the regulator registrations or accreditations for the type of study, and whether its past studies were accepted by your target regulator.
- A quality agreement. It should say who releases batches, who handles complaints and recalls, and how changes are notified.
- Documents you will receive. For a CDMO, the CMC sections of the dossier in CTD or ACTD format. Our guide to CTD vs ACTD explains the difference.
Where to go next
Our CDMO and contract manufacturing guide hub links every PharmaTradz guide on choosing and working with manufacturers, including 50+ leading CDMO companies in India and top global CDMOs. If you know your dosage form, start with our contract manufacturing pages for tablets, hard capsules, softgels and oral liquids.
Tell us what you need developed or made, and for which market: send an RFQ. Manufacturers and CDMOs can list their capabilities to reach buyers.
Frequently Asked Questions(FAQs)
What is the full form of CDMO?
CDMO stands for Contract Development and Manufacturing Organisation: a company that develops a medicine's formulation and process for a client and then manufactures it.
What is the difference between a CDMO and a CMO?
A CMO manufactures to a process the client already has. A CDMO also does the development work: formulation, scale-up, stability studies and the technical documents needed for registration.
What is the difference between a CRO and a CDMO?
A CRO runs research and studies, such as clinical trials and bioequivalence studies, and delivers data. A CDMO develops and makes the product itself. Many projects need both.
What does CMO mean in pharma?
In outsourcing it means Contract Manufacturing Organisation. In a company's leadership team, the same letters usually mean Chief Medical Officer.
What is a CRDMO?
A Contract Research, Development and Manufacturing Organisation: a company that adds discovery and research chemistry to development and manufacturing, so a client can stay with one partner from early research to commercial supply.
Who owns the dossier when a CDMO develops a product?
Whoever the development agreement says. Some CDMOs develop for a fee and transfer everything; others fund development, keep the dossier and license it. Agree this in writing before work starts.
